It is known that suppression is greater in tumours with high ER and PgR and in those negative for HER2[14] but the degree to which these relationships are independent of one another and of commonly measured clinico-pathological features could not be established in the modest sized studies to date. Here, ERBB2 is linked to neoplasm.